EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Claudins in Cancer: A Current and Future Therapeutic Target

Caroline Hana iD, Nyein Nyein Thaw Dar, Michael Galo Venegas, Michel Vulfovich

International Journal of Molecular Sciences · 24.04.2024 · 25 (9) · 4634

DOI: 10.3390/ijms25094634 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.04.2024. Verfasst von Caroline Hana und 3 weiteren Autor:innen. Beteiligte Einrichtung: Hematology/Oncology Department, Memorial Healthcare System, Pembroke Pines, FL 33028, USA. Hauptthemen laut MEDLINE: Claudins, Neoplasms. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 213 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Claudins are a family of 27 proteins that have an important role in the formation of tight junctions. They also have an important function in ion exchange, cell mobility, and the epithelial-to-mesenchymal transition, the latter being very important in cancer invasion and metastasis. Therapeutic targeting of claudins has been investigated to improve cancer outcomes. Recent evidence shows improved outcomes when combining monoclonal antibodies against claudin 18.2 with chemotherapy for patients with gastroesophageal junction cancer. Currently, chimeric antigen receptor T-cells targeting claudin 18 are under investigation. In this review, we will discuss the major functions of claudins, their distribution in the normal as well as cancerous tissues, and their effect in cancer metastasis, with a special focus on the therapeutic targeting of claudins to improve cancer outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClaudinsNeoplasmsHumansAnimalsEpithelial-Mesenchymal TransitionMolecular Targeted TherapyTight Junctions

Stichwörter der Autor:innen

CAR-T cell therapycarcinomaclaudinmonoclonal antibodiestargeted therapy

Substanzen

Claudins

Autor:innen und Institutionen

  • Hematology/Oncology Department, Memorial Healthcare System, Pembroke Pines, FL 33028, USA.

ORCID-Profile: Caroline Hana

Zitieren

APA

Hana, C., Thaw Dar, N. N., Galo Venegas, M., & Vulfovich, M. (2024). Claudins in Cancer: A Current and Future Therapeutic Target. International Journal of Molecular Sciences, 25(9), 4634. https://doi.org/10.3390/ijms25094634

Vancouver

Hana C, Thaw Dar NN, Galo Venegas M, Vulfovich M. Claudins in Cancer: A Current and Future Therapeutic Target. International Journal of Molecular Sciences. 2024;25(9):4634. doi:10.3390/ijms25094634

BibTeX
@article{Hana2024,
  author = {Hana, Caroline and Thaw Dar, Nyein Nyein and Galo Venegas, Michael and Vulfovich, Michel},
  title = {Claudins in Cancer: A Current and Future Therapeutic Target},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {9},
  pages = {4634},
  doi = {10.3390/ijms25094634}
}
Kostenlos starten →